| 中文名称： | Lanopepden |
| smiles： | FC1=C(N=C(C)N=C1N1CCN2CCOC[C@@H]2C1)NNC([C@@H](CN(C=O)O)CC1CCCC1)=O |
| 英文名称： | Lanopepden |
| 英文别名： | N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide;((2R)-2-cyclopentylmethyl-3-(2-(5-fluoro-6-((9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)-2-methyl-4-pyrimidinyl)hydrazino)-3-oxopropyl)hydroxyforrmamide;[(2R)-2-(cyclopentylmethyl)-3-(2-{5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl}hydrazino)-3-oxopropyl]hydroxyformamide;GSK-322;GSK-1322322;UNII-12M6KFD07E;N-((R)-2-(CYCLOPENTYLMETHYL)-3-(2-(5-FLUORO-6-((S)-HEXAHYDROPYRAZINO[2,1-C][1,4]OXAZIN-8(1H)-YL)-2-METHYLPYRIMIDIN-4-YL)HYDRAZINYL)-3-OXOPROPYL)-N-HYDROXYFORMAMIDE;N-((R)-2-(CYCLOPENTYLMETHYL)-3-(2-(5-FLUORO-6-((S)-HEXAHYDROPYRAZINO[2,1-C][1,;Lanopepden;Lanopepden (USAN/INN);Q27251425;[(2R)-2-(cyclopentyl methyl)-3-(2-{5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl}hydrazino)-3-oxopropyl]hydroxyformamide;CYCLOPENTANEPROPANOIC ACID, .ALPHA.-((FORMYLHYDROXYAMINO)METHYL)-, 2-(5-FLUORO-6-((9AS)-HEXAHYDROPYRAZINO(2,1-C)(1,4)OXAZIN-8(1H)-YL)-2-METHYL-4-PYRIMIDINYL)HYDRAZIDE, (.ALPHA.R)-;Cyclopentanepropanoic acid, a-[(formylhydroxyamino)methyl]-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, (aR)-;Cyclopentanepropanoic acid, alpha-[(formylhydroxyamino)methyl]-, 2-[5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl]hydrazide, (alphaR)-;DA-64858;NS00072567;D10712;GSK1322322;BDBM50535502;DB11912;1152107-25-9 (free base);DTXSID00151006;HY-12480;CHEMBL3301608;GLXC-20619;CS-0011738;GSK-1322322B;SWHNZGMQMGFQGW-MSOLQXFVSA-N;1152107-25-9;Lanopepden [USAN:INN];LANOPEPDEN [INN];12M6KFD07E;LANOPEPDEN [USAN];AKOS027321270;LANOPEPDEN [WHO-DD];SCHEMBL1189985;Cyclopentanepropanoic acid, alpha-((formylhydroxyamino)methyl)-, 2-(5-fluoro-6-((9as)-hexahydropyrazino(2,1-c)(1,4)oxazin-8(1H)-yl)-2-methyl-4-pyrimidinyl)hydrazide, (alphar)-;GSK 1322322;GSK1322322B;NB4;N-[(2R)-2-(cyclopentylmethyl)-3-(2-{5-fluoro- 6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]- 2-methylpyrimidin-4-yl}hydrazin-1-yl)-3-oxopropyl]- N-hydroxyformamide |
| CAS号： | 1152107-25-9 |
| 分子式： | C22H34FN7O4 |
| 分子量： | 479.55 |
| 密度： | |
| 熔点： | |
| 沸点： | |
| 闪点： | |
| 水溶性： | |
| 蒸气压： |
Lanopepden
英文名：
Lanopepden
别名：
商品编号：R223749-2mg
规格：2mg
纯度：98.62%
CAS号： 1152107-25-9
分子式：C22H34FN7O4
分子量：479.55
| 价格 |
¥ 8490.00
（请 登录 会员查看折扣价）
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 8490.00
¥ 8490.00
¥ 8490.00
¥ 8490.00
¥ 8490.00
¥ 8490.00
¥ 8490.00
¥ 8490.00
¥ 8490.00
¥ 8490.00
